Lifeist Wellness (TSE:LFST)
:LFST
Top Page
Lifeist Wellness
(LFST)
Select Model
Select Model
Rating:43Neutral
Price Target:
C$0.04
▼(-2.50% Downside)
Action:ReiteratedDate:04/10/26
The score is primarily held down by very weak financial performance—persistent losses, recurring negative operating/free cash flow, and a severe recent revenue contraction. Technical indicators are broadly neutral and do not meaningfully offset the fundamental deterioration, while valuation is constrained by negative earnings and no dividend support.
Positive Factors
Low reported debt
Reported zero total debt in 2024–2025 materially reduces interest and near-term refinancing risk, giving the company structural balance-sheet flexibility. This lowers fixed financial obligations and preserves capacity to raise capital or fund operations during a multi‑quarter restructuring or turnaround.
Negative Factors
Consistent unprofitability
Persistent negative EBIT and net income across reported periods show the business is not currently generating operating profits. Over 2–6 months this undermines retained capital, reduces reinvestment capacity, and increases dependence on external financing to support operations or execute strategic initiatives.
Read all positive and negative factors
Positive Factors
Negative Factors
Low reported debt
Reported zero total debt in 2024–2025 materially reduces interest and near-term refinancing risk, giving the company structural balance-sheet flexibility. This lowers fixed financial obligations and preserves capacity to raise capital or fund operations during a multi‑quarter restructuring or turnaround.
Read all positive factors
Lifeist Wellness (LFST) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$1.52M
Dividend YieldN/A
Average Volume (3M)27.14K
Price to Earnings (P/E)―
Beta (1Y)1.39
Revenue Growth-98.28%
EPS Growth76.18%
CountryCA
Employees72
SectorConsumer Defensive
Sector Strength42
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)N/A
Shares Outstanding37,885,635
10 Day Avg. Volume60,599
30 Day Avg. Volume27,139
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)2.15
Price to Sales (P/S)9.88
P/FCF Ratio-0.85
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Lifeist Wellness Business Overview & Revenue Model
Company Description
Lifeist Wellness Inc. operates as a wellness company in the United States and Canada. The company operates CannMart.com, an online marketplace for hemp-derived CBD and accessories; and Findify, an artificial intelligence powered technology platfor...
How the Company Makes Money
Lifeist Wellness generates revenue primarily through the sale of products and services produced and distributed by its operating subsidiaries/brands, where applicable (e.g., direct-to-consumer and/or wholesale sales of wellness/health-oriented con...
Lifeist Wellness Financial Statement Overview
Summary
Income Statement
12
Very Negative
Balance Sheet
38
Negative
Cash Flow
9
Very Negative
| Breakdown | Nov 2025 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 249.37K | 588.80K | 21.66M | 22.07M | 21.15M |
| Gross Profit | -845.37K | 204.75K | 5.34M | 3.79M | 120.29K |
| EBITDA | -2.39M | -3.99M | -5.96M | -17.44M | -20.25M |
| Net Income | -2.99M | -1.45M | -14.13M | -15.44M | -23.80M |
Balance Sheet | |||||
| Total Assets | 1.84M | 5.13M | 13.40M | 20.67M | 37.96M |
| Cash, Cash Equivalents and Short-Term Investments | 781.81K | 2.34M | 1.45M | 3.80M | 12.74M |
| Total Debt | 0.00 | 0.00 | 1.27M | 328.33K | 554.59K |
| Total Liabilities | 688.62K | 1.06M | 9.94M | 7.30M | 11.89M |
| Stockholders Equity | 1.15M | 4.07M | 3.46M | 13.36M | 26.06M |
Cash Flow | |||||
| Free Cash Flow | -2.90M | -877.20K | -2.79M | -16.04M | -18.64M |
| Operating Cash Flow | -2.90M | -877.20K | -2.46M | -15.35M | -18.28M |
| Investing Cash Flow | 1.34M | 1.92M | 1.28K | 6.69M | -229.57K |
| Financing Cash Flow | 0.00 | -169.19K | 83.82K | -252.29K | 21.02M |
Lifeist Wellness Technical Analysis
Negative
0.04
Price Trends
0.04
Positive
0.05
Negative
0.07
Negative
Market Momentum
<0.01
Positive
48.74
Neutral
33.33
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:LFST, the sentiment is Negative. The current price of 0.04 is below the 20-day moving average (MA) of 0.04, above the 50-day MA of 0.04, and below the 200-day MA of 0.07, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 48.74 is Neutral, neither overbought nor oversold. The STOCH value of 33.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:LFST.
Lifeist Wellness Peers Comparison
UnderperformOutperform
Sector (62)
TSE:LFST
Lifeist Wellness
0.04
0.00
0.00%
TSE:MGW
Maple Leaf Green World
0.03
>-0.01
-16.67%
TSE:WIB
West Island Brands Inc
0.13
0.00
0.00%
TSE:TCAN
TransCanna Holdings Inc
0.01
0.00
0.00%
TSE:SILO
Silo Wellness Inc
0.01
0.00
0.00%
Lifeist Wellness Corporate Events
Business Operations and StrategyExecutive/Board Changes
Lifeist Adds Interim CEO and CFO Lachlan McLeod to Board in Governance Shift
Positive
Mar 31, 2026
Lifeist Wellness Inc., a health and wellness company focused on building and integrating leading consumer wellness brands, counts U.S.-based Mikra Cellular Sciences as its principal biosciences asset, developing innovative products for the post-pa...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.